Market Tracker

11/21 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.5734
Data as of Nov 21
 -0.0766 / -11.78%
Today’s Change
0.45
Today|||52-Week Range
7.15
-90.55%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close0.65
Today’s open0.66
Day’s range0.57 - 0.68
Volume885,149
Average volume (3 months)645,372
Market cap$20.5M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.04-1.47%
BSPMBiostar Pharmaceutic...+0.04+3.08%
RGDXResponse Genetics In...+0.03+5.77%
REPCFRepliCel Life Scienc...-0.02-3.75%
Data as of 3:59pm ET, 11/21/2014

Financials

Last reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts